Mr. Yash Gupta - Equity Research Associate, Angel Broking Ltd
"Pfizer informed the coronavirus vaccine that its trials are in the last stage and results will come by the end of october. Pfizer submitted a proposal to USFDA to expand the last stage trials to include up to 44000 participants, which is a significant increase from the previous participant of 3000.If company got approval from USFDA then company is prepared to distribute Hundreds of thousands of doses by the end of the year. This is positive development for the company as well as global markets."
Shares of PFIZER LTD. was last trading in BSE at Rs.4900 as compared to the previous close of Rs. 4874.75. The total number of shares traded during the day was 6035 in over 1785 trades.
The stock hit an intraday high of Rs. 5040.6 and intraday low of 4875. The net turnover during the day was Rs. 29869531.